isomiRTar: a comprehensive portal of pan-cancer 5'-isomiR targeting

Stepan Nersisyan1,2,3,4, Aleksandra Gorbonos4, Alexey Makhonin4

  • 1Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.

Peerj
|October 24, 2022
PubMed

Insights

MicroRNA (miRNA) isoforms, or isomiRs, with 5'-end variations (5'-isomiRs) have distinct targets in cancer. The isomiRTar portal analyzes these 5'-isomiRs, revealing cancer-specific landscapes and potential tumor suppressors.

Area of Science:

  • Molecular Biology
  • Genomics
  • Bioinformatics

Background:

  • MicroRNAs (miRNAs) regulate gene expression through specific seed regions.
  • Inaccurate processing of miRNA precursors generates miRNA isoforms known as isomiRs.
  • IsomiRs with 5'-end variations (5'-isomiRs) possess distinct seed regions and targetomes, impacting gene regulation.

Purpose of the Study:

  • To develop isomiRTar, a comprehensive portal for analyzing 5'-isomiR expression and targeting in cancer.
  • To identify and characterize 5'-isomiRs across various cancer types using The Cancer Genome Atlas (TCGA) data.

Main Methods:

  • Compiled a list of 1022 5'-isomiRs from 9282 tumor samples across 31 cancer types using TCGA data.
  • Predicted target genes for identified 5'-isomiRs using miRDB and TargetScan.
  • Performed co-expression analysis to identify robust isomiR-target pairs with significant negative correlations.

Main Results:

  • Discovered distinct cancer-specific and conserved 5'-isomiR expression patterns.
  • Demonstrated that 5'-isomiRs differing by a single nucleotide shift have largely non-overlapping targetomes (median Jaccard index of 0.06).
  • Identified potential tumor suppressor 5'-isomiRs in colorectal cancer, including hsa-miR-203a-3p-+1, hsa-miR-192-5p-+1, and hsa-miR-148a-3p-0.

Conclusions:

  • The isomiRTar portal provides a valuable resource for exploring 5'-isomiR expression and targeting in cancer.
  • 5'-isomiR variations contribute to the complexity of miRNA-mediated gene silencing.
  • This resource facilitates the discovery of novel isomiR-mediated regulatory mechanisms in cancer biology.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
639
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K